Harbor Investment Advisory, LLC Crispr Therapeutics Ag Transaction History

Harbor Investment Advisory, LLC

  • $1.26 Billion
  • Q4 2024

A detailed history of Harbor Investment Advisory, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Harbor Investment Advisory, LLC holds 4,455 shares of CRSP stock, worth $180,382. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,455
Previous 5,805 23.26%
Holding current value
$180,382
Previous $272,000 35.66%
% of portfolio
0.01%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025
SELL
$38.65 - $55.15 $52,177 - $74,452
-1,350 Reduced 23.26%
4,455 $175,000
Q3 2024

Oct 04, 2024
SELL
$44.62 - $62.75 $892 - $1,255
-20 Reduced 0.34%
5,805 $272,000
Q2 2024

Jul 19, 2024
SELL
$51.17 - $68.18 $17,653 - $23,522
-345 Reduced 5.59%
5,825 $314,000
Q4 2023

Jan 26, 2024
SELL
$38.62 - $72.18 $17,379 - $32,481
-450 Reduced 6.8%
6,170 $386,000
Q3 2023

Oct 13, 2023
SELL
$45.39 - $59.0 $181 - $236
-4 Reduced 0.06%
6,620 $300,000
Q2 2023

Jul 14, 2023
SELL
$43.47 - $67.77 $23,908 - $37,273
-550 Reduced 7.67%
6,624 $371,000
Q1 2023

Apr 21, 2023
SELL
$41.0 - $56.12 $28,700 - $39,284
-700 Reduced 8.89%
7,174 $324,000
Q4 2022

Jan 24, 2023
SELL
$39.19 - $65.67 $127,367 - $213,427
-3,250 Reduced 29.22%
7,874 $0
Q3 2022

Nov 01, 2022
SELL
$61.1 - $83.78 $12,220 - $16,756
-200 Reduced 1.77%
11,124 $727,000
Q2 2022

Jul 18, 2022
SELL
$43.23 - $73.83 $2,161 - $3,691
-50 Reduced 0.44%
11,324 $688,000
Q1 2022

Apr 20, 2022
SELL
$53.19 - $79.24 $221,802 - $330,430
-4,170 Reduced 26.83%
11,374 $714,000
Q4 2021

Jan 10, 2022
SELL
$70.09 - $111.29 $37,147 - $58,983
-530 Reduced 3.3%
15,544 $1.18 Million
Q3 2021

Oct 12, 2021
SELL
$110.2 - $156.64 $35,264 - $50,124
-320 Reduced 1.95%
16,074 $1.8 Million
Q2 2021

Jul 27, 2021
BUY
$100.84 - $161.89 $35,294 - $56,661
350 Added 2.18%
16,394 $2.65 Million
Q1 2021

Apr 16, 2021
BUY
$110.72 - $210.04 $74,846 - $141,987
676 Added 4.4%
16,044 $1.96 Million
Q4 2020

Feb 04, 2021
BUY
$79.67 - $173.23 $248,570 - $540,477
3,120 Added 25.47%
15,368 $2.35 Million
Q3 2020

Oct 23, 2020
SELL
$78.5 - $100.64 $134,313 - $172,195
-1,711 Reduced 12.26%
12,248 $1.02 Million
Q2 2020

Jul 16, 2020
BUY
$38.5 - $76.05 $140,756 - $278,038
3,656 Added 35.48%
13,959 $1.03 Million
Q1 2020

May 11, 2020
BUY
$33.68 - $62.53 $27,078 - $50,274
804 Added 8.46%
10,303 $437,000
Q4 2019

Jan 16, 2020
BUY
$36.68 - $73.13 $348,423 - $694,661
9,499 New
9,499 $579,000

Others Institutions Holding CRSP

# of Institutions
485
Shares Held
58.9M
Call Options Held
1.09M
Put Options Held
1.9M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.16B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Harbor Investment Advisory, LLC Portfolio

Follow Harbor Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbor Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email